Ashland Non-GAAP EPS of $1.12 misses by $0.15, revenue of $498M misses by $3.82M (NYSE:ASH)

Ashland Inc. reported Q4 Non-GAAP EPS of $1.12, missing estimates by $0.15, and revenue of $498M, missing by $3.82M. The company's earnings fell short of analysts' expectations.

Original reporting
Published Nov 3, 2026, 10:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ASH
Bearish
high confidence
Mentioned
$ASH
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$ASHBearishMed
01

Why it matters

The earnings shortfall is likely to trigger a price decline in the immediate trading session.

02

Market read

The earnings miss is material for Ashland shareholders and may influence related chemical stocks.

03

What to watch

Potential cost‑saving initiatives or upcoming contract wins not disclosed yet could mitigate the impact.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Ashland Inc. (NYSE:ASH) is a specialty chemicals company. The press release provides the first public disclosure of its Q4 2026 earnings.

Company-level read

Ticker impact

$ASHBearishHigh confidence
Context

Ashland reported Q4 Non-GAAP EPS of $1.12, missing expectations by $0.15 and revenue of $498M, missing by $3.82M.

Expected impact

likely downward pressure as market prices in the earnings shortfall

Evidence & confidence

Both EPS and revenue fell short of consensus, which typically triggers a sell‑off in the near term.

Market effects

May weigh on specialty chemicals peers as earnings miss signals sector pressure.

Limited to U.S. markets; no broader regional effect.

Low global relevance beyond chemical industry investors.

Counterpoint

If the miss is due to one‑off items, the stock could rebound on a short‑term oversell.

Key entities

  • Ashland Inc.

    Specialty chemicals producer reporting Q4 earnings.

Related articles

$ASHMed

Here’s Why Ashland (ASH) is Targeted by Activist Investors for an Outright Sale

Ashland Inc. (ASH) is targeted by activist investors Ancora Advisors and Cruiser Capital Advisors for a potential outright sale, according to a Q3 2026 review by Harvard Law School. The investors argue that Ashland's businesses could be worth more separately, with Ancora estimating a sale could generate $76 per share, a 33% premium to the share price at the time. Ashland operates in specialty chemicals across four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates.

$ASHHighAI 8/10

Ashland Inc (ASH) (Q4 2026) Earnings Call Highlights: Record Life Sciences Margins

Ashland Inc (ASH) reported Q4 2026 earnings with record Life Sciences margins at 35.6% and Personal Care sales up 8%. Specialty Additives EBITDA declined due to Hopewell productivity issues. Fiscal 2027 guidance projects EBITDA of $405M-$435M, reflecting operational challenges and currency headwinds. Cash flow from operations was $90M, up from $40M in the prior year quarter. The company expects foreign currency to be a headwind in fiscal 2027.

$ASHMed

What Ashland (ASH) Said on Its Q4 Earnings Call

Ashland (ASH) reported Q4 Personal Care sales up 8% to $163M, with adjusted EBITDA rising 14% to $49M. The company expects double-digit growth in biofunctional actives and microbial protection. Specialty Additives sales were flat, but adjusted EBITDA fell to $20M. Ashland forecasts $140M in capital expenditures for fiscal 2027, with a foreign-exchange headwind of $20M-$25M in sales.

$ASHHighAI 8/10

Ashland Inc. (ASH) Q4 2026 Earnings Call Transcript

Ashland Inc. (ASH) reported Q4 2026 sales of $498M, up 4% YoY, with Life Sciences and Personal Care segments driving growth. Adjusted EBITDA rose 2% to $121M, while adjusted EPS increased to $1.12. The company highlighted strong cash flow and plans to focus on growth and margin improvement in fiscal 2027, according to management.

$ASHHighAI 8/10

Ashland Q4 FY26 slides: cash flow strength lifts stock despite EPS miss

Ashland Global Holdings (NYSE:ASH) reported Q4 FY26 earnings of $1.12 per share, missing estimates but beating on cash flow. Revenue rose 4% to $498M. Shares gained 3.2% on strong cash flow and FY27 outlook. CEO Novo declared transformation complete, focusing on growth. Life Sciences and Personal Care segments performed well, while Specialty Additives faced margin pressures. FY27 guidance: sales $1.905B-$1.975B, EBITDA $405M-$435M.